source
- Cardiovascular biotech Kardigan raises $400M in IPO, fourth 2026 $400M+ offeringKardigan, a cardiovascular drug startup, priced a $400 million initial public offering on Wednesday, adding to a recent surge in large biotech offerings. The company becomes the fourth biotech in…
- Eli Lilly stops 340B discounts for dozens of hospitals that did not submit claims dataEli Lilly has begun removing the federally mandated 340B price discounts for a few dozen hospitals that have not provided the required claims data. The company said the step follows a warning it is…